1 Min Read
May 3 (Reuters) - Nymox Pharmaceutical Corp:
* Nymox files for marketing approval for fexapotide triflutate in Europe Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.